The American Diabetes Association (ADA) in January appointed William T. Cefalu, MD, its chief scientific and medical officer (CSMO) and reported the renowned physician, educator, and researcher will begin serving in this role on February 20. He replaces Robert E. Ratner, MD, who retired on December 31 after serving as CSMO for nearly five years.
Cefalu has been associate editor of the ADA’s journals Diabetes and Diabetes Care since 2004 and editor in chief of Diabetes Care since 2012, and will assist in that publication’s transition to new editorial leadership.
He joins the ADA from Louisiana State University’s Pennington Biomedical Research Center in Baton Rouge, where he continues to serve as executive director and the George A. Bray, Jr. Endowed Super Chair in Nutrition.
In the January issue of Diabetes Care, the ADA published a new position statement on diabetic neuropathy that includes a classification of diabetic neuropathies and recommendations for prevention, diabetic autonomic neuropathies, atypical neuropathies, and neuropathy endpoints for research and clinical trials.
Read the full statement at care.diabetesjournals.org.